Press Release

<< Back

IRIDEX to Report Fourth Quarter and 2016 Financial Results on March 8, 2017

MOUNTAIN VIEW, Calif., Feb. 22, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release financial results for the fourth quarter and 2016 after the close of trading on Wednesday, March 8, 2017.  The Company's management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for international callers, using conference ID: 61156151. A live and archived webcast of the event will be available on the "Investor Relations" section of the Company's website at: www.iridex.com. A telephone replay will also be available beginning Wednesday, March 8, 2017 through Thursday, March 9, 2017 by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers, using conference ID: 61156151.

About IRIDEX
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the IRIDEX website at http://www.iridex.com/.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/iridex-to-report-fourth-quarter-and-2016-financial-results-on-march-8-2017-300411583.html

SOURCE IRIDEX Corporation

Lynn Pieper Lewis or Leigh Salvo, (415) 937-5404, investors@iridex.com

logo aa0 logo ags logo ascrs logo asrs logo esrs0 logo euretina